Undervalued Stocks Based on Artificial Intelligence: Up To 11.83% return in 7 Days

Package Name: Top 10 Stocks
Forecast Length: 7 Days (12/22/15 – 12/29/15)
I Know First Average: 3.36%

Read The Full Forecast

Undervalued Stocks

Best ETF’S Based on Algorithms: Up To 16.85% Returns in 14 Days

Package Name: ETFs Forecast
Forecast Length: 14 Days (12/15/2015 - 12/29/2015)
I Know First Average: 5.53%

Read The Full Forecast

Best ETF'S

Commodities Prices: Up to 20.42% Return in 1 Month

Forecast Length: 1 month (11/29/15 - 12/29/15)

Read The Full Forecast

Commodities Prices

Machine Learning for Trading: Up to 61.10% Returns in 3 Months

Package Name: Tech Stocks
Forecast Length: 3 Months (09/25/15 – 12/25/15)
I Know First Average: 19.38%

Read The Full Forecast

Machine Learning for Trading

Stock Analysis Based On Artificial Intelligence: Up To 169.90% Return In 1 Year

Package Name: Risk-Conscious
Forecast Length: 1 year (12/28/2014 - 12/28/2015)
I Know First Average: 26.59%

Read The Full Forecast

aggresive 1 year

Best Stock Screener Based on Artificial Intelligence : Up to 75.38% Returns in 3 Months

Package Name: Tech Stocks
Forecast Length: 3 Months (09/28/15 – 12/28/15)
I Know First Average: 14.50%

See The Full Forecast

Best Stock Screener

Global Market Forecast for 2016 Based On A Predictive Algorithm

reuben 2Reuben Bor is a Financial Analyst Intern at I Know First
  • 11378-illustration-of-a-globe-with-borders-pvIn 2015, our strongest signal for a bullish outlook on the Italian index yielded strong returns as did our bearish projections for the Australian index
  • Shanghai Composite Index performed quite well despite market correction
  • In 2016, we recommend investing in Ireland and avoiding Russia and Malaysia

premiumRead The Full Premium Article

Subscribe to our exclusive content in the PREMIUM section

I Know First Review: CELG New Partnership

I Know First Review I Know First also wrote a Seeking Alpha article about Celgene on Nov 23rd, 2015. in accordance to the I Know First algorithmic signal. Claiming that improving the lives of patients worldwide will improve the lives of patient investors showing off their sales for 3Q increase of 12% to $1,453mn. Since that time, the stock price has increased 8%.

Read The Full Forecast